文献速递贫血与红细胞疾病

如何管理儿童钻石-布莱克凡贫血

How I manage children with Diamond-Blackfan anaemia.
PubMed 文献 · Br J Haematol · 2018-12-04

钻石-布莱克凡贫血(DBA)是一种罕见的遗传性骨髓衰竭性疾病,以低增生性贫血、先天畸形和因核糖体功能障碍导致的癌症易感性为特征。目前糖皮质激素和/或输血是基础治疗,但伴有显著毒性和长期后遗症;干细胞移植是唯一可治愈血液学表型的选项。本文综述当前知识并给出DBA患者日常管理建议。

要点

  • DBA以低增生性贫血、先天畸形和癌症易感性为特征。
  • 糖皮质激素和/或输血是基础治疗,但毒性和长期后遗症显著。
  • 干细胞移植是目前唯一可治愈血液学DBA表型的选项。

核心结论

  • 干细胞移植是目前唯一可治愈血液学DBA表型的选项,但仍有必要开发新疗法和生物学见解以改善所有DBA患者的临床照护。

研究设计与样本

  • 本文为综述,提供当前知识和DBA患者日常照护建议的概述。

主要发现

  • DBA是一种罕见的遗传性骨髓衰竭性疾病,由核糖体功能障碍导致低增生性贫血、先天畸形和癌症易感性。
  • 历史上治疗基于糖皮质激素和/或输血,伴有显著毒性和长期后遗症。
  • 干细胞移植在过去十年中于选定患者中相当成功。

临床怎么用

  • 除儿科血液科医生外,其他医生(如内分泌科医生、妇科医生)最好从早期就参与这种慢性病的照护。
  • 多学科参与旨在改善血液学和非血液学症状的终身管理,并筛查DBA相关恶性肿瘤。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diamond-Blackfan anaemia (DBA) is a rare inherited marrow failure disorder, characterized by hypoplastic anaemia, congenital anomalies and a predisposition to cancer as a result of ribosomal dysfunction. Historically, treatment is based on glucocorticoids and/or blood transfusions, which is accompanied by significant toxicity and long-term sequelae. Currently, stem cell transplantation is the only curative option for the haematological DBA phenotype. Whereas this procedure has been quite successful in the last decade in selected patients, novel therapies and biological insights are still warranted to improve clinical care for all DBA patients. In addition to paediatric haematologists, other physicians (e.g. endocrinologist, gynaecologist) should ideally be involved in the care of this chronic condition from an early age, to improve lifelong management of haematological and non-haematological symptoms, and screen for DBA-associated malignancies. Here we provide an overview of current knowledge and recommendations for the day-to-day care of DBA patients.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Bartels M, Bierings M. How I manage children with Diamond-Blackfan anaemia. Br J Haematol. 2018. PMID: 30515771. doi:10.1111/bjh.15701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。